HONG KONG, 16 August 2024–(BUSINESS WIRE)–Plastec Technologies, Ltd. (OTCBB: PLTYF) (the “Company”) today announced its unaudited financial results for the six-month period ended June 30, 2024. Financial tables/amounts at the end of this publication are in Hong Kong dollars (HK$), while all other amounts are presented in U.S. dollars ($), based on an exchange rate […]
Apollomics Inc. FOSTER CITY, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) — Apollomics Incl. (Nasdaq: APLM) (“Apollomics” or the “Company”), an advanced clinical-stage biopharmaceutical company developing multiple oncology drug candidates to treat difficult-to-treat and treatment-resistant cancers, today announced financial results for the first half of 2024 ended June 30, 2024, and highlighted updates to its pipeline. […]
Vancouver, British Columbia–(Newsfile Corp. – August 13, 2024) – Neotech Metals Corp. (CSE: NTMC) (OTC Pink: NTMFF) (FSE: V690) (“Neotech” or the “Pursue“), announces that it has finalized the terms of its non-brokered private placement financing LIFE (the “Offer“), which was previously announced on June 24, 2024. The total proceeds will be at least $1,350,000 […]
Sunrise New Energy Co., Ltd ZIBO, China, Aug. 13, 2024 (GLOBE NEWSWIRE) — Sunrise New Energy Co., Ltd. (“Sunrise”, the “Company”, “we” or “our”) (NASDAQ: EPOW) today announced that the Guizhou Provincial Radio and Television Channel’s “Finance Qianxinan” program featured an interview with Mr. Haiping Hu, the founder and CEO of Sunrise. The report highlighted […]
Maris Tech Ltd. Due to strong demand for the company’s defense and AI solutions, gross revenues increased for the six-month period ended on 30 June 2024, increased by approx. 630% – 720% compared to the same six months Period In 2023. The Company is expected to publish its financial statements for The six–Monthly period until […]
Oxford BioMedica plc Half-year trading update and interim results announcement Revenue and medium-term financial guidance for full year 2024 reaffirmed; underpinned by OXB’s growing market share in the expanding cell and gene therapy market The contracted value of customer orders in the first seven months of the year, at around £80 million, reflects strong demand […]
